menu
    • menu

    Company profile for Convergent Therapeutics

    NEW Drugs in Dev: 3
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Convergent Therapeutics, Inc. is a biotechnology company focused on developing next-generation targeted combination therapies to treat cancer.Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakt...
    Convergent Therapeutics, Inc. is a biotechnology company focused on developing next-generation targeted combination therapies to treat cancer.Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Convergent TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, MA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://convergentrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/convergent-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Convergent Reports Positive Phase 2 CONV01-? Data at ASCO
    Convergent Reports Positive Phase 2 CONV01-? Data at ASCO

    01 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260601939715/en/Convergent-Therapeutics-Announces-Positive-Phase-2-Data-at-ASCO-2026-Showing-Promising-Anti-Tumor-Activity-Durability-and-Favorable-Tolerability-for-CONV01--in-Lu-PSMA-Exposed-Metastatic-Castration-Resistant-Prostate-Cancer-mCRPC

    BUSINESSWIRE
    01 Jun 2026
    Share Share
    Convergent Shows Phase 2 Alpha Radiopharmaceutical Data at ASCO
    Convergent Shows Phase 2 Alpha Radiopharmaceutical Data at ASCO

    21 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260521939719/en/Convergent-Therapeutics-to-Present-Largest-Set-of-Prospective-Phase-2-Data-for-an-Alpha-Radiopharmaceutical-in-Lu-PSMA-Exposed-Metastatic-Castration-Resistant-Prostate-Cancer-at-ASCO-2026

    BUSINESSWIRE
    21 May 2026
    Share Share
    Convergent Therapeutics Names Andrew Davis CBO And CSO
    Convergent Therapeutics Names Andrew Davis CBO And CSO

    29 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7247791

    FIRSTWORD PHARMA
    29 Apr 2026
    Share Share
    Convergent Therapeutics Names Andrew Davis as Chief Strategy
    Convergent Therapeutics Names Andrew Davis as Chief Strategy

    29 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260429803038/en/Convergent-Therapeutics-Names-Andrew-Davis-Chief-Business-and-Strategy-Officer

    BUSINESSWIRE
    29 Apr 2026
    Share Share
    Convergent Therapeutics To Unveil CONV01-? Phase 2 Results
    Convergent Therapeutics To Unveil CONV01-? Phase 2 Results

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/convergent-therapeutics-to-present-phase-2-data-for-conv01-?-in-lu-psma-pretreated-metastatic-castra

    PHARMIWEB
    21 Apr 2026
    Share Share
    Radiotherapeutics Moment: Isotopes are Changing Cancer Treatment
    Radiotherapeutics Moment: Isotopes are Changing Cancer Treatment

    02 Apr 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/the-radiotherapeutics-moment-how-isotopes-are-changing-cancer-treatment

    BIOSPACE
    02 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search